These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Neutron therapy of endometrial cancer using californium-252 sources of high activity]. Kiseleva VN; Savinova VF; Mar'ina LA; Chekhonadskiĭ VN Vopr Onkol; 1988; 34(9):1070-4. PubMed ID: 3188432 [TBL] [Abstract][Full Text] [Related]
25. [Contact neutron therapy of tumors with 252Cf irradiation]. Vtiurin BM Med Radiol (Mosk); 1987 Sep; 32(9):62-7. PubMed ID: 3657457 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of the characteristics of the neutron reference field using D2O-moderated 252Cf source. Kowatari M; Fujii K; Takahashi M; Yoshizawa M; Shimizu S; Kawasaki K; Yamaguchi Y Radiat Prot Dosimetry; 2007; 126(1-4):138-44. PubMed ID: 17525058 [TBL] [Abstract][Full Text] [Related]
27. [Dosimetry in interstitial radiotherapy using neutrons]. Díez de los Ríos A; Martínez Morillo M Rev Esp Oncol; 1982; 29(2):301-6. PubMed ID: 7188231 [TBL] [Abstract][Full Text] [Related]
28. Neutron brachytherapy in the modern era: Indications and evidence. Loap P; Barcellini A; de Marzi L; Orlandi E; Kirova Y Cancer Radiother; 2023 Apr; 27(2):170-177. PubMed ID: 36759242 [TBL] [Abstract][Full Text] [Related]
29. Neutron-based sterilization of anthrax contamination. Liu B; Wang Q Health Phys; 2006 May; 90(5 Suppl):S80-4. PubMed ID: 16607173 [TBL] [Abstract][Full Text] [Related]
30. Status of dosimetry for 252Cf medical neutron sources. Anderson LL Phys Med Biol; 1973 Nov; 18(6):779-99. PubMed ID: 4591580 [No Abstract] [Full Text] [Related]
32. Calculated and experimentally determined neutron dose conversion factor for Californium. Stone DR; Wagner EB; Jones TD; Shinpaugh WH Health Phys; 1970 Jan; 18(1):69-71. PubMed ID: 5414969 [No Abstract] [Full Text] [Related]
33. Potentialities and feasibility of neutron therapy of cancer. Brennan JT Proc Natl Cancer Conf; 1970; 6():289-92. PubMed ID: 5458099 [No Abstract] [Full Text] [Related]
34. The content of 250Cf and 248Cm in 252Cf neutron sources and the effect on the neutron emission rate. Roberts NJ; Jones LN Radiat Prot Dosimetry; 2007; 126(1-4):83-8. PubMed ID: 17502315 [TBL] [Abstract][Full Text] [Related]
35. [Microdosimetric characteristics of the neutron spectrum of 252Cf fission and of the P-2 and B-3 beams from the BP-10 reactor]. Pitkevich VA; Videnskiĭ VG Med Radiol (Mosk); 1978 Oct; 23(10):47-52. PubMed ID: 703547 [No Abstract] [Full Text] [Related]
36. [Neutron flow measurements in the d(14) + Be neutron radiation field from the cyclotron in Essen]. Pöller F; Sauerwein W; Rau D; Wagner FM; Olthoff K; Rassow J; Sack H Strahlenther Onkol; 1990 Jun; 166(6):426-9. PubMed ID: 2363106 [TBL] [Abstract][Full Text] [Related]
37. Californium-252 line sources: experimental verification of depth dose data using NTA films and dosage tables based on Paterson and Parker rules. Iyer PS; Gopalakrishnan AK; Venkataraman G Phys Med Biol; 1976 Jan; 21(1):98-103. PubMed ID: 815921 [TBL] [Abstract][Full Text] [Related]
38. Experimental and theoretical study of the neutron dose produced by carbon ion therapy beams. Iwase H; Gunzert-Marx K; Haettner E; Schardt D; Gutermuth F; Kraemer M; Kraft G Radiat Prot Dosimetry; 2007; 126(1-4):615-8. PubMed ID: 17522032 [TBL] [Abstract][Full Text] [Related]
39. [Principles of dosimetric planning in contact therapy with highly active Cf-252 sources]. Chekhonadskij VN; Merkle K Strahlenther Onkol; 1987 Nov; 163(11):742-5. PubMed ID: 3686338 [TBL] [Abstract][Full Text] [Related]